Ropeginterferon as Effective but Safer Than Hydroxyurea in Polycythemia Vera
Targeted Oncology Patients were randomized to treatment with either ropeginterferon or HU, with the primary endpoint being non-inferiority of ropeginterferon compared with HU at 12 months of therapy on the CHR rate, defined as hematocrit <45% without phlebotomy (at ... |
from phlebotomy - Google News http://bit.ly/2g84ntU
No comments:
Post a Comment